logo
Plus   Neg
Share
Email

Roche: FDA Approves Cobas Babesia Test For Blood Donation Testing - Quick Facts

Roche (RHHBY) has received FDA approval for the cobas Babesia test for use on the cobas 6800/8800 Systems for individual blood donation testing. Cobas Babesia detects parasites that live in red blood cells. Roche said the whole blood test to screen donations follows May 2019 FDA-updated industry guidance recommending testing for Babesia parasite.

"With the approval of Roche's first whole blood test used in blood screening we can help healthcare professionals further diminish potential risks of infection from transfused blood products," said Thomas Schinecker, CEO Roche Diagnostics.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. is taking necessary precautions including Covid-19 testing for those employees returning to work at its headquarters in Silicon Valley, Bloomberg reported citing people familiar with the process. The company, which opened its main Apple Park office in May bringing back some hardware and software engineers, plans the gradual reopening of the building keeping the coronavirus safeguards. A U.S. appeals court has blocked the sales of Bayer AG's dicamba-based Xtendimax in the United States. The three-judge panel in the U.S. Court of Appeals for the Ninth Circuit ruled that the US Environmental Protection Agency (EPA) overstated the protections and substantially understated or ignored the risks related to the use of dicamba-based herbicides. Tesla Chief Executive Officer Elon Musk has called for a breakup of Amazon after the online retail giant refused to publish an upcoming book about COVID-19. Writer Alex Berenson said on Twitter that Amazon refused to publish his booklet about the coronavirus as it did not comply with the company's guidelines. Berenson is a former New York Times reporter.
Follow RTT